Nurses use AI Echo for Heart Failure detection in Australia

Us2.ai has been chosen as the AI software solution for the PANACEA-HF project — an ambitious, federally funded initiative aimed at transforming early heart failure diagnosis and care across Australia.

Led by Professor Simon Stewart from the University of Notre Dame in Western Australia, the study is part of a $2 million grant from the Medical Research Future Fund (MRFF). Over the next four years, the project will trial portable, AI-guided technologies — including software from Us2.ai — in community clinics and patient homes to detect signs of heart failure in its earliest stages.

The project, Practice Nurses to Augment the Clinical Evaluation and Care of people at high-risk of Heart Failure (PANACEA-HF), empowers practice nurses to lead heart health screenings using easy-to-use tools like iPads and handheld ultrasound probes. With the support of Us2.ai’s automated echocardiography software, the goal is to simplify and scale early detection of heart failure, especially in underserved or remote settings.

By combining human expertise with AI-powered precision, the PANACEA-HF study represents a new frontier in preventive care — one where early diagnosis, timely intervention, and equitable access come together to improve outcomes nationwide.

If successful, the team plans to present the findings to the Australian federal government with the goal of nationwide adoption of this AI-enabled model in every general practice.

At Us2.ai, we’re honoured to support this initiative and help bring scalable, high-quality cardiac care to more people.

Read more about the project in recent news coverage: